TOKYO - Japan's audit board has requested the health ministry provide supporting documentation for contracts with U.S and British coronavirus vaccine manufacturers after finding a weak basis for ordering a total of 882 million doses in fiscal 2020 and 2021.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
